July 12, 2014 5:43 AM ET

Capital Markets

Company Overview of Oxford Bioscience Partners IV, L.P.

Company Overview

Oxford Bioscience Partners IV, L.P. specializes in early-stage investments. It invests exclusively in the life sciences, with a focus on genomics, biotechnology, medical technology, e-Health, and medical device companies.

535 Boylston Street

Suite 402

Boston, MA 02116

United States

Founded in 2001

Phone:

617-357-7474

Fax:

617-357-7476

Key Executives for Oxford Bioscience Partners IV, L.P.

Managing General Partner
Age: 57
Senior General Partner
Age: 77
General Partner
Age: 45
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Headwaters Capital, LLC United States
Access Securities, Inc. United States
Primus Financial Products, LLC United States
Broadridge Corporate Issuer Solutions, Inc. United States
Bendigo Securities, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 1, 2013
CircuLite, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxford Bioscience Partners IV, L.P., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.